Cancer Epidemiology (CE) The goal of the Cancer Epidemiology (CE) Program is to provide a platform to synergize research efforts of epidemiologic and clinical researchers in order to elucidate pathways to cancer occurrence and progression that can impact clinical treatment and prevention strategies. The program brings together experienced, NCI- funded epidemiologists, molecular biologists, biostatisticians, bioinformaticists and NCCC clinicians around 3 central interactive program themes: (1) population genomics, (2) emerging risk factors, and (3) life course epidemiology. Program investigators design, execute, and analyze population-based research aimed at understanding cancer etiology, second malignancies, progression, and survival, as well as develop novel methods for these lines of research. This work is based on outstanding efforts to use population-based studies of the catchment area population and also to engage in research with national and international epidemiologic resources, including clinical trials, cohort and case-control studies. Currently there are 22 members, including 3 clinical members and 1 joint member, spanning 11 departments with expertise and experience in all facets of modern molecular epidemiology. The NCCC has been instrumental in supporting the efforts of the CE program, most notably with its support of strategic, targeted recruitment efforts, including the recruitment of Chris Amos, Olga Gorlova, Jennifer Doherty, Diane Gilbert-Diamond, Scott Williams, Amarendra Das, Zhigang Li, Brock Christensen and Carmen Marsit, the latter who serves now as Co-Director of the program with Margaret Karagas. Spurred by these recruitments and their synergies with existing member interests, the present program has developed and evolved, from a broader program in Cancer Epidemiology and Chemoprevention, to focus its efforts on cancer epidemiology research and translation. The program aims to expand collaborative research efforts within its membership and across NCCC Programs, utilizing monthly program meetings to encourage these activities, which are subsequently catalyzed by pilot grants funded by NCCC. The support of the NCCC was paramount in the successful creation and funding of the new COBRE Center for Molecular Epidemiology, the development of an interdisciplinary training program in the Quantitative Population Sciences in Cancer, and a second COBRE in Integrative Biology. These initiatives have been instrumental in the recruitment of talented faculty and trainees that continue to energize and grow cancer epidemiology research. More than 580 cancer-related articles have been published over the reporting period (85 [15%] in high impact journals), with all 22 members on intra-program (158=27%) and 19 members on inter- program (74=13%) collaborations. Total funding for the program is currently $11.5M, of which $10.8M is peer- reviewed and $2.9M is from NCI. These efforts will allow the CE program to continue to perform cutting-edge molecular epidemiologic research, on the etiology and outcomes of cancer, to reduce the burden of human malignancies and impact prevention and treatment strategies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA023108-36
Application #
8804016
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-08-04
Project End
2019-11-30
Budget Start
2015-02-19
Budget End
2015-11-30
Support Year
36
Fiscal Year
2015
Total Cost
$66,027
Indirect Cost
$25,269
Name
Dartmouth College
Department
Type
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Andrew, Angeline S; Chen, Celia Y; Caller, Tracie A et al. (2018) Toenail mercury Levels are associated with amyotrophic lateral sclerosis risk. Muscle Nerve :
Gacerez, Albert T; Sentman, Charles L (2018) T-bet promotes potent antitumor activity of CD4+ CAR T cells. Cancer Gene Ther 25:117-128
Yang, Wei; Schwartz, Gary N; Marotti, Jonathan D et al. (2018) Estrogen receptor alpha drives mTORC1 inhibitor-induced feedback activation of PI3K/AKT in ER+ breast cancer. Oncotarget 9:8810-8822
Anderson, Joseph C; Butterly, Lynn F; Robinson, Christina M et al. (2018) Risk of Metachronous High-Risk Adenomas and Large Serrated Polyps in Individuals With Serrated Polyps on Index Colonoscopy: Data From the New Hampshire Colonoscopy Registry. Gastroenterology 154:117-127.e2
Zhao, Yanding; Varn, Frederick S; Cai, Guoshuai et al. (2018) A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma. Cancer Epidemiol Biomarkers Prev 27:86-95
Lyons, Kathleen Doyle; Newman, Robin; Adachi-Mejia, Anna M et al. (2018) Content Analysis of a Participant-Directed Intervention to Optimize Activity Engagement of Older Adult Cancer Survivors. OTJR (Thorofare N J) 38:38-45
Vergo, Maxwell T; Pinkson, Briane M; Broglio, Kathleen et al. (2018) Immediate Symptom Relief After a First Session of Massage Therapy or Reiki in Hospitalized Patients: A 5-Year Clinical Experience from a Rural Academic Medical Center. J Altern Complement Med 24:801-808
Gacerez, Albert T; Hua, Casey K; Ackerman, Margaret E et al. (2018) Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expression. Cancer Immunol Immunother 67:749-759
Onega, T; Zhu, W; Weiss, J E et al. (2018) Preoperative breast MRI and mortality in older women with breast cancer. Breast Cancer Res Treat 170:149-157
Lott, Jason P; Boudreau, Denise M; Barnhill, Ray L et al. (2018) Population-Based Analysis of Histologically Confirmed Melanocytic Proliferations Using Natural Language Processing. JAMA Dermatol 154:24-29

Showing the most recent 10 out of 1911 publications